J07A Bacterial vaccines
J07AC
Anthrax vaccines
Anthrax vaccines are vaccines to prevent the livestock and human disease anthrax, caused by the bacterium ''Bacillus anthracis''.
They have had a prominent place in the history of medicine, from Pasteur's pioneering 19th-century work with cattle ...
:J07AC01 Anthrax antigen
J07AD Brucellosis vaccines
:J07AD01 Brucella antigen
J07AE
Cholera vaccine
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85percent protection, which decreases to 50percent or 62percent during the first year. After two years the leve ...
s
:J07AE01 Cholera, inactivated, whole cell
:J07AE02 Cholera, live attenuated
:J07AE51 Cholera, combinations with typhoid vaccine, inactivated, whole cell
J07AF
Diphtheria vaccine
Diphtheria vaccine is a toxoid vaccine against diphtheria, an illness caused by ''Corynebacterium diphtheriae''. Its use has resulted in a more than 90% decrease in number of cases globally between 1980 and 2000. The first dose is recommended ...
s
:J07AF01
Diphtheria toxoid
Diphtheria vaccine is a toxoid vaccine against diphtheria, an illness caused by ''Corynebacterium diphtheriae''. Its use has resulted in a more than 90% decrease in number of cases globally between 1980 and 2000. The first dose is recommended a ...
J07AG ''Haemophilus influenzae'' B vaccines
:J07AG01 Hemophilus influenzae B, purified antigen conjugated
:J07AG51 Hemophilus influenzae B, combinations with toxoids
:J07AG52
Hemophilus influenzae B, combinations with pertussis and toxoids
:J07AG53 Hemophilus influenzae B, combinations with meningococcus C, conjugated
:J07AG54 Haemophilus influenza B, combinations with meningococcus C,Y, conjugated
J07AH
Meningococcal vaccine
Meningococcal vaccine refers to any vaccine used to prevent infection by ''Neisseria meningitidis''. Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. The vaccines are between 85 ...
s
:J07AH01 Meningococcus A, purified polysaccharides antigen
:J07AH02 Other meningococcal monovalent purified polysaccharides antigen
:J07AH03 Meningococcus A, C, bivalent purified polysaccharides antigen
:J07AH04 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen
:J07AH05 Other meningococcal polyvalent purified polysaccharides antigen
:J07AH06 Meningococcus B, outer membrane vesicle vaccine
:J07AH07 Meningococcus C, purified polysaccharides antigen conjugated
:J07AH08 Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated
:J07AH09 Meningococcus B, multicomponent vaccine
:J07AH10 Meningococcus A, purified polysaccharides antigen conjugated
J07AJ
Pertussis vaccine
Pertussis vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effectiv ...
s
:J07AJ01 Pertussis, inactivated, whole cell
:J07AJ02 Pertussis, purified antigen
:J07AJ51
Pertussis, inactivated, whole cell, combinations with toxoids
:J07AJ52
Pertussis, purified antigen, combinations with toxoids
J07AK
Plague vaccine
Plague vaccine is a vaccine used against ''Yersinia pestis'' to prevent the plague. Inactivated bacterial vaccines have been used since 1890 but are less effective against the pneumonic plague, so live, attenuated vaccines and recombinant protein ...
s
:J07AK01 Plague, inactivated, whole cell
J07AL
Pneumococcal vaccine
Pneumococcal vaccines are vaccines against the bacterium ''Streptococcus pneumoniae''. Their use can prevent some cases of pneumonia, meningitis, and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide va ...
s
:J07AL01
Pneumococcus, purified polysaccharides antigen
:J07AL02
Pneumococcus, purified polysaccharides antigen conjugated
:J07AL52 Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated
J07AM
Tetanus vaccine
Tetanus vaccine, also known as tetanus toxoid (TT), is a toxoid vaccine used to prevent tetanus. During childhood, five doses are recommended, with a sixth given during adolescence.
After three doses, almost everyone is initially immune, but a ...
s
:J07AM01 Tetanus toxoid
:J07AM51 Tetanus toxoid, combinations with diphtheria toxoid
:J07AM52 Tetanus toxoid, combinations with tetanus immunoglobulin
J07AN
Tuberculosis vaccines
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch.Prabowo, S. et al. "Targeting multidrug-resistant tuberculosis (MDR-TB) by ...
:J07AN01
Tuberculosis
Tuberculosis (TB) is an infectious disease usually caused by ''Mycobacterium tuberculosis'' (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in w ...
, live attenuated
J07AP
Typhoid vaccine
Typhoid vaccines are vaccines that prevent typhoid fever. Several types are widely available: typhoid conjugate vaccine (TCV), Ty21a (a live oral vaccine) and Vi capsular polysaccharide vaccine (ViPS) (an injectable subunit vaccine). They are ab ...
s
:J07AP01
Typhoid, oral, live attenuated
:J07AP02 Typhoid, inactivated, whole cell
:J07AP03
Typhoid, purified polysaccharide antigen
:J07AP10 Typhoid, combinations with paratyphi types
J07AR Typhus (exanthematicus) vaccines
:J07AR01 Typhus exanthematicus, inactivated, whole cell
J07AX Other bacterial vaccines
:J07AX01
Leptospira vaccines
''Leptospira'' ( grc, leptos, italics=yes, 'fine, thin' and la, spira, links=no, 'coil') is a genus of spirochaete bacteria, including a small number of pathogenic and saprophytic species. ''Leptospira'' was first observed in 1907 in kidney ti ...
J07B Viral vaccines
J07BA
Encephalitis
Encephalitis is inflammation of the Human brain, brain. The severity can be variable with symptoms including reduction or alteration in consciousness, headache, fever, confusion, a stiff neck, and vomiting. Complications may include seizures, hal ...
vaccines
:J07BA01
Encephalitis, tick-borne
Tick-borne encephalitis (TBE) is a viral infectious disease involving the central nervous system. The disease most often manifests as meningitis, encephalitis or meningoencephalitis. Myelitis and spinal paralysis also occurs. In about one thi ...
, inactivated, whole virus
:J07BA02
Encephalitis, Japanese
Japanese encephalitis (JE) is an infection of the brain caused by the Japanese encephalitis virus (JEV). While most infections result in little or no symptoms, occasional inflammation of the brain occurs. In these cases, symptoms may include h ...
, inactivated, whole virus
:J07BA03 Encephalitis, Japanese, live attenuated
J07BB
Influenza vaccines
Influenza vaccines, also known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies fro ...
:J07BB01
Influenza
Influenza, commonly known as "the flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptom ...
inactivated, whole virus
:J07BB02 Influenza, purified antigen
:J07BB03 Influenza, live attenuated
:J07BB04 Influenza, virus like particles
J07BC
Hepatitis
Hepatitis is inflammation of the liver parenchyma, liver tissue. Some people or animals with hepatitis have no symptoms, whereas others develop yellow discoloration of the skin and whites of the eyes (jaundice), Anorexia (symptom), poor appetite ...
vaccines
:J07BC01
Hepatitis B
Hepatitis B is an infectious disease caused by the '' Hepatitis B virus'' (HBV) that affects the liver; it is a type of viral hepatitis. It can cause both acute and chronic infection.
Many people have no symptoms during an initial infection. F ...
, purified antigen
:J07BC02
Hepatitis A
Hepatitis A is an infectious disease of the liver caused by ''Hepatovirus A'' (HAV); it is a type of viral hepatitis. Many cases have few or no symptoms, especially in the young. The time between infection and symptoms, in those who develop the ...
, inactivated, whole virus
:J07BC20
Combinations
J07BD
Measles vaccine
Measles vaccine protects against becoming infected with measles. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When rate of vaccination within a population is greater than 92%, outbreaks o ...
s
:J07BD01 Measles, live attenuated
:J07BD51 Measles, combinations with
mumps
MUMPS ("Massachusetts General Hospital Utility Multi-Programming System"), or M, is an imperative, high-level programming language with an integrated transaction processing key–value database. It was originally developed at Massachusetts Gen ...
, live attenuated
:J07BD52
Measles, combinations with mumps and rubella, live attenuated
:J07BD53 Measles, combinations with
rubella
Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and ...
, live attenuated
:J07BD54
Measles, combinations with mumps, rubella and varicella, live attenuated
J07BE
Mumps vaccine
Mumps vaccines are vaccines which prevent mumps. When given to a majority of the population they decrease complications at the population level. Effectiveness when 90% of a population is vaccinated is estimated at 85%. Two doses are required fo ...
s
:J07BE01
Mumps, live attenuated
J07BF Poliomyelitis vaccines
:J07BF01
Poliomyelitis
Poliomyelitis, commonly shortened to polio, is an infectious disease caused by the poliovirus. Approximately 70% of cases are asymptomatic; mild symptoms which can occur include sore throat and fever; in a proportion of cases more severe sym ...
oral, monovalent live attenuated
:J07BF02
Poliomyelitis
Poliomyelitis, commonly shortened to polio, is an infectious disease caused by the poliovirus. Approximately 70% of cases are asymptomatic; mild symptoms which can occur include sore throat and fever; in a proportion of cases more severe sym ...
oral, trivalent, live attenuated
:J07BF03
Poliomyelitis
Poliomyelitis, commonly shortened to polio, is an infectious disease caused by the poliovirus. Approximately 70% of cases are asymptomatic; mild symptoms which can occur include sore throat and fever; in a proportion of cases more severe sym ...
, trivalent, inactivated, whole virus
:J07BF04
Poliomyelitis
Poliomyelitis, commonly shortened to polio, is an infectious disease caused by the poliovirus. Approximately 70% of cases are asymptomatic; mild symptoms which can occur include sore throat and fever; in a proportion of cases more severe sym ...
oral, bivalent, live attenuated
J07BG
Rabies vaccine
The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for a period of time, after exposure to the rabies virus, ...
s
:J07BG01
Rabies, inactivated, whole virus
J07BH
Rotavirus diarrhea vaccine
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of se ...
s
:J07BH01
Rotavirus, live attenuated
:J07BH02
Rotavirus, pentavalent, live, reassorted
J07BJ
Rubella vaccine
Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubell ...
s
:J07BJ01
Rubella, live attenuated
:J07BJ51 Rubella, combinations with mumps, live attenuated
J07BK Varicella zoster vaccines
:J07BK01
Varicella, live attenuated
:J07BK02
Zoster, live attenuated
:J07BK03
Zoster, purified antigen
J07BL
Yellow fever vaccine
Yellow fever vaccine is a vaccine that protects against yellow fever. Yellow fever is a viral infection that occurs in Africa and South America. Most people begin to develop immunity within ten days of vaccination and 99 percent are protected ...
s
:J07BL01 Yellow fever, live attenuated
J07BM Papillomavirus vaccines
:J07BM01
Papillomavirus (human types 6, 11, 16, 18)
:J07BM02
Papillomavirus (human types 16, 18)
:J07BM03 Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
J07BN
Covid-19 vaccine
A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID19).
Prior to the COVID19 pandemic, an est ...
s
:J07BN01
Covid-19, RNA-based vaccine
:J07BN02
Covid-19, viral vector, non-replicating
:J07BN03
Covid-19, inactivated virus
:J07BN04
Covid-19, protein subunit
J07BX Other viral vaccines
:J07BX01
Smallpox vaccine
The smallpox vaccine is the first vaccine to be developed against a contagious disease. In 1796, British physician Edward Jenner demonstrated that an infection with the relatively mild cowpox virus conferred immunity against the deadly smallpox ...
s
:J07BX02
Ebola vaccine
Ebola vaccines are vaccines either approved or in development to prevent Ebola. As of 2022, there are only vaccines against the Zaire ebolavirus. The first vaccine to be approved in the United States was rVSV-ZEBOV in December 2019. It had be ...
s
:J07BX04
Dengue virus vaccines
J07C Bacterial and viral vaccines
J07CA Bacterial and viral vaccines, combined
:J07CA01
Diphtheria-poliomyelitis-tetanus
:J07CA02
Diphtheria-pertussis-poliomyelitis-tetanus
:J07CA03 Diphtheria-rubella-tetanus
:J07CA04 Hemophilus influenzae B and poliomyelitis
:J07CA05
Diphtheria-hepatitis B-pertussis-tetanus
:J07CA06
Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus
:J07CA07 Diphtheria-hepatitis B-tetanus
:J07CA08
Hemophilus influenzae B and hepatitis B
:J07CA09
Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
:J07CA10
Typhoid-hepatitis A
:J07CA11
Diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B
:J07CA12
Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
:J07CA13 Diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C
J07X Other vaccines
J07XA Parasitic vaccines
:J07XA01
Malaria vaccines
See also
* Vaccines for veterinary use are in the
ATCvet
The Anatomical Therapeutic Chemical (ATC) Classification System is a drug classification system that classifies the active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemica ...
group
QI.
References
{{Vaccines
J07